Total raised: $168M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.06.2024 | - | $168M | - |
Mentions in press and media 4
| Date | Title | Description |
| 20.06.2024 | Santa Ana Bio: Revolutionizing Precision Medicine for Inflammatory Diseases | Santa Ana Bio, a precision immunology company, has secured a whopping $168 million in funding to advance their groundbreaking therapies for autoimmune and inflammatory diseases. The company's innovative approach targets disease-causing cell... |
| 19.06.2024 | Santa Ana Bio: Inflammatory Disease Precision Medicine Company Raises $168 Million | Santa Ana Bio, a precision immunology company developing targeted therapies for patients with autoimmune and inflammatory diseases, emerged from stealth with $168 million in combined Series A and B funding. Versant Ventures, founding invest... |
| 13.06.2024 | Santa Ana Bio Raises $168M in Funding | Santa Ana Bio, an Alameda, CA-based precision immunology company, raised $168M in combined Series A and B funding. Founding investor Versant Ventures led the Series A round and was joined by TPG’s Life Science Innovations fund and GV. The $... |
| - | Santa Ana Bio | “Santa Ana Bio” |